CDSCO License for Electrocardiograph electrode
Medical Device Information
Intended Use
An electrocardiograph electrode is the electrical conductor which is applied to the surface of the body to transmit the electrical signal at the body surface to a processor that produces an electrocardiogram or vectorcardiogram.

Comprehensive Guide to CDSCO Licensing for Electrocardiograph Electrodes (Class B Medical Device)
Electrocardiograph electrodes play a crucial role in cardiovascular diagnostics by transmitting electrical signals from the body surface to the processing unit that generates electrocardiograms or vectorcardiograms. As a Class B medical device under the Indian regulatory framework, these electrodes must comply with the Central Drugs Standard Control Organization (CDSCO) requirements to ensure market access and patient safety. With over 25 years of experience assisting more than 500 companies, we provide a detailed roadmap for manufacturers and importers aiming to secure CDSCO approval for electrocardiograph electrodes.
CDSCO Regulatory Framework for Electrocardiograph Electrodes
The CDSCO regulates medical devices under the Medical Device Rules, 2017, incorporating risk-based classification. Electrocardiograph electrodes fall under Class B (low to moderate risk). This classification mandates obtaining a State Licensing Authority manufacturing license, known as the MD5 license, before commercialization in India.
The notification 29/Misc./03/2020-DC (159), dated 26.7.2021, specifically includes electrocardiograph electrodes in the cardiovascular device category, emphasizing compliance with essential principles and quality requirements.
Risk Classification and License Requirements for Class B Devices
Class B devices require manufacturers to apply for the MD5 license using Application Form MD3 through the State Licensing Authority. The process involves several steps including obtaining a test license, product testing, audit by a notified body, and finally, license grant. Importers should note that import licenses are distinct and covered separately.
For detailed classification guidance, manufacturers can refer to the Medical Device Classification guide.
Manufacturing License Process (MD5) for Electrocardiograph Electrodes
- Test License Application (Form MD13): Initial step to obtain permission to manufacture and test the device, taking approximately 1.5 to 2 months.
- Product Testing: Mandatory testing of electrocardiograph electrodes at CDSCO-approved labs to verify compliance with safety and performance standards. Refer to the Testing Laboratories list for approved facilities.
- Document Preparation: Compilation of technical and quality documents including Device Master File, Plant Master File, Risk Management File, and others.
- License Application (Form MD3): Submission of the manufacturing license application for MD5 through the CDSCO MD Online Portal.
- Audit by Notified Body: An audit of the manufacturing site and quality systems conducted by a CDSCO-recognized notified body. The list of such bodies is available on the Notified Bodies List.
- Query Resolution: Addressing any observations or queries raised during audit or by the licensing authority.
- Grant of License (Form MD5): Upon satisfactory compliance, the State Licensing Authority issues the manufacturing license.
Manufacturing License Documents Required for Electrocardiograph Electrodes
- Company constitution documents (e.g., partnership deed, incorporation certificate)
- Proof of ownership or lease of manufacturing premises
- Details and qualifications of technical staff
- Fire safety and pollution NOCs
- Device Master File detailing design, specifications, and manufacturing processes (Device Master File Guide)
- Plant Master File describing manufacturing environment and equipment (Plant Master File Guide)
- Essential Principles Checklist confirming compliance with Indian standards
- Risk Management File outlining hazard analysis and mitigation (Risk Management Guide)
- Product test reports from CDSCO-approved labs
- Labels and Instructions For Use (IFU)
- Quality Management System (QMS) documents, preferably ISO 13485 certified
Import License Process (MD15) for Electrocardiograph Electrodes
Importers of electrocardiograph electrodes must apply for an MD15 license granted by the Central Licensing Authority. Unlike manufacturing, import licensing does not require a test license but demands comprehensive documentation including manufacturing license from the country of origin, Free Sale Certificate, ISO 13485 certification, CE certificate (if applicable), and detailed device and plant master files.
The process typically spans 5-6 months and involves submission of Form MD14 via the CDSCO MD Online Portal, followed by query resolution and license grant.
For further details, refer to our Import License Guide.
Import License Documents Required
- Valid manufacturing license from the manufacturer’s country
- Free Sale Certificate
- ISO 13485:2016 certificate
- CE Certificate (if marketed in Europe)
- Device Master File and Plant Master File
- Wholesale license for importers
- Company constitution documents
- Manufacturing license (if applicable)
Timeline and Processing Duration
Process Step | Duration (Approx.) |
---|---|
Test License (MD13) | 1.5 to 2 months |
Product Testing | 3 to 4 weeks |
Document Preparation | 2 to 3 weeks |
License Application (MD3) | Immediate upon document readiness |
Audit by Notified Body | 3 to 4 weeks |
Query Resolution | 2 to 3 weeks |
Final License Grant (MD5) | Total approx 3 to 4 months |
Government Fees and Costs
- Application fee: INR 5,000 per application
- Product fee: INR 500 per product
- Additional costs include notified body audit fees (varies by auditor) and laboratory testing fees
Budgeting for these fees upfront helps avoid delays. For more on MD5 fees and process, see our detailed MD5 License Guide.
Common Challenges and Solutions
Challenge: Delays in product testing due to backlogs at government labs.
Solution: Engage early with approved labs and consider parallel document preparation during testing.
Challenge: Incomplete or inconsistent documentation leading to audit observations.
Solution: Leverage expert consultation to prepare Device and Plant Master Files and ensure all quality management aspects are covered.
Challenge: Misunderstanding risk classification leading to incorrect license application.
Solution: Verify classification using CDSCO guidelines and seek professional advice to confirm the need for MD5 license.
Expert Consultation and Support
Navigating CDSCO licensing for electrocardiograph electrodes demands precise documentation, thorough testing, and strategic planning. Our 25+ years of regulatory expertise and hands-on experience with over 500 companies empower manufacturers to avoid common pitfalls and accelerate approvals.
We assist with:
- Comprehensive gap analysis of technical files
- Coordination with notified bodies and testing labs
- Preparation and review of master files and risk management documents
- Application submission and query resolution
Getting Started with Your CDSCO License Application
- Assess Your Device Classification: Confirm that your electrocardiograph electrode is Class B.
- Prepare Technical Documentation: Begin compiling the Device and Plant Master Files, essential principles checklist, and risk management files.
- Apply for Test License: Submit Form MD13 via the CDSCO MD Online Portal to start manufacturing for testing.
- Engage an Approved Testing Laboratory: Schedule product testing early to align with your timeline.
- Plan for Audit: Identify and coordinate with a notified body from the official Notified Bodies List to conduct your manufacturing site audit.
- Submit Manufacturing License Application: Upon successful testing and audit, apply for the MD5 license (Form MD3) online.
- Respond to Queries Promptly: Ensure timely and comprehensive responses to expedite license grant.
Taking these proactive steps will position your electrocardiograph electrode product for successful entry into the Indian market. Our expert consultants stand ready to assist you at every stage to ensure compliance and minimize time to market.
For personalized support, contact us to leverage our deep expertise in CDSCO medical device licensing.